Finally, WHO has some good news for 213 covid-19 impacted countries
Category: #health  By Nikita Chaurasia  Date: 2020-09-04
  • share
  • Twitter
  • Facebook
  • LinkedIn

Finally, WHO has some good news for 213 covid-19 impacted countries

The World Health Organization on Wednesday reported that widely available and low-cost corticosteroids can aid covid-19 positive patients suffering from serious symptoms. The body also warned against the use of corticosteroids on patients with non-severe symptoms.

As per the scientific evidences from the eight randomized clinical trials, WHO suggests systemic corticosteroid may decrease 28-day mortality in covid-19 patients at critical stage. About 87 less deaths per 1000 patients were recorded using this steroid an about 67 less deaths per 1,000 patients in patients with severe disease.

WHO developed the cure in collaboration with Magic Evidence Ecosystem Foundation, a non-profit organization which provides methodologic support for developing and disseminating living guidance for covid-19 drug treatment.

In June this year, WHO released the outcomes of initial clinical trials conducted at Oxford University, showing dexamethasone to be lifesaving for severely ill covid-19 patients. For patients on ventilators, the treatment reduced deaths by a third and for patients requiring only oxygen, the death toll dropped by a fifth.

Moreover, early lab studies from a team of pharmacologists and researchers showed promise for an ‘out of the box’ alternative, a plant-based drug for treating coronavirus. The team found that an edible weed could potentially assist in inhibiting the viral infection, cite credible sources.

WHO on the matter said that there are still a lot of uncertainties regarding covid-19 treatment modalities and there are many avenues which need to be explored. WHO stated that lot of variables exhibit long-term impact of systemic corticosteroids in covid-19 survivors and will serve as important references for the future.

WHO also said that investigational therapies including remdesivir should be compared with systemic corticosteroids or assessed together with systemic corticosteroids instead of systemic corticosteroids alone.

Source: https://www.livemint.com/news/india/some-readily-available-steroids-can-be-life-saving-in-severe-covid-cases-who-11599101820424.html

  • share
  • Twitter
  • Facebook
  • LinkedIn


About Author

Nikita Chaurasia    

Nikita Chaurasia

Having always been daft at wordplay, Nikita Chaurasia, post the completion of post-graduation, commenced her journey into the content generation cosmos. Endowed with a professional MBA degree in Advertising and Public Relations, Nikita strives to integrate her creativ...

Read More

More News By Nikita Chaurasia

Syndax Pharmaceuticals reveals data from phase 1 trial of axatilimab
Syndax Pharmaceuticals reveals data from phase 1 trial of axatilimab
By Nikita Chaurasia

According to reliable sources, Massachusetts-headquartered clinical stage biopharmaceutical company, Syndax Pharmaceuticals Inc. has revealed an updated data from its Phase 1 trial of its patent axatilimab. The company will reportedly present the dat...

Xiaomi shares drop by 7.1% after raising USD 3.9 billion in equity deal
Xiaomi shares drop by 7.1% after raising USD 3.9 billion in equity deal
By Nikita Chaurasia

Shares of Xiaomi Corporation, a Chinese multinational electronics company, witnessed a 7.1% drop during Hong Kong trading after the company secured USD 3.91 billion in fund raising which also included the city’s top-up placement. The company h...

Supercom signs a supply contract of PureSecurity EM suite in Wisconsin
Supercom signs a supply contract of PureSecurity EM suite in Wisconsin
By Nikita Chaurasia

Israel-based leading provider of advanced solutions for cybersecurity, IoT (Internet of Things) and e-Government sectors Supercom has reportedly signed a supply agreement to deliver its PureSecurity EM (Electronic Monitoring) product suite in Wiscons...